CRP and metabolic dysfunction-associated steatotic liver disease: Compared with the patients without NAFLD, the former group exhibited a higher proportion of males and higher smoking rates, a greater prevalence of family history of CVD, diabetes and hypertension, elevated BMI, uric acid, ALT, AST, TG, hs-CRP, and APRI levels, as well as a lower HDL-C level.